saikosaponin d has been researched along with Allodynia in 2 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 2 (100.00) | 2.80 |
Authors | Studies |
---|---|
Chen, L; Liu, Y; Xiang, Q | 1 |
Choi, J; Choi, Y; Kim, JK; Kim, P; Kim, S; Kim, WJ; Lee, G; Lee, JH; Lee, JK; Lee, JS; Nam, YJ; No, KT; Song, MJ | 1 |
2 other study(ies) available for saikosaponin d and Allodynia
Article | Year |
---|---|
Saikosaponin d (SSD) alleviates diabetic peripheral neuropathy by regulating the AQP1/RhoA/ROCK signaling in streptozotocin-induced diabetic rats.
Topics: Animals; Aquaporin 1; Blood Glucose; Body Weight; Diabetes Mellitus, Experimental; Diabetic Neuropathies; Hyperalgesia; Rats; Rats, Sprague-Dawley; rho-Associated Kinases; rhoA GTP-Binding Protein; Saponins; Signal Transduction; Streptozocin | 2023 |
Identification and characterization of saikosaponins as antagonists of transient receptor potential A1 channel.
Topics: Animals; Drug Evaluation, Preclinical; HEK293 Cells; Humans; Hyperalgesia; Male; Mice; Mice, Inbred ICR; Molecular Docking Simulation; Neuralgia; Oleanolic Acid; Pain Measurement; Saponins; TRPA1 Cation Channel | 2020 |